Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Montelukast and Nasal Epithelial Cell Inflammatory Responses in Asthma and Rhinitis

The recruitment status of this study is unknown because the information has not been verified recently.
Verified October 2010 by University of Aberdeen.
Recruitment status was  Not yet recruiting
Sponsor:
Collaborator:
Merck Sharp & Dohme Corp.
Information provided by:
University of Aberdeen
ClinicalTrials.gov Identifier:
NCT01230437
First received: October 27, 2010
Last updated: October 28, 2010
Last verified: October 2010
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is not yet open for participant recruitment.
  Estimated Study Completion Date: December 2011
  Estimated Primary Completion Date: December 2011 (Final data collection date for primary outcome measure)